UroGen Pharma Ltd. - Ordinary Shares (URGN): Price and Financial Metrics

UroGen Pharma Ltd. - Ordinary Shares (URGN): $15.27

0.14 (-0.91%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add URGN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#129 of 307

in industry

URGN Price/Volume Stats

Current price $15.27 52-week high $17.00
Prev. close $15.41 52-week low $3.42
Day low $14.89 Volume 1,061,273
Day high $15.80 Avg. volume 1,606,083
50-day MA $10.35 Dividend yield N/A
200-day MA $0.00 Market Cap 705.49M

URGN Stock Price Chart Interactive Chart >


UroGen Pharma Ltd. - Ordinary Shares (URGN) Company Bio


UroGen Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing therapies for urological pathologies. The company is developing its product candidates as chemoablation agents, which are designed to remove tumors by non-surgical means, to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial carcinoma, and low-grade bladder cancer. The company was founded in 2004 and is based in Raanana, Israel.


URGN Latest News Stream


Event/Time News Detail
Loading, please wait...

URGN Latest Social Stream


Loading social stream, please wait...

View Full URGN Social Stream

URGN Price Returns

1-mo 2.69%
3-mo N/A
6-mo 48.69%
1-year -8.23%
3-year 68.17%
5-year -39.50%
YTD 43.38%
2024 -29.00%
2023 69.11%
2022 -6.73%
2021 -47.23%
2020 -46.00%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!